The present findings necessitate the adoption of an interventional program to reduce the risk of hypoglycemia in our country by adherence to the guidelines and reduction of sulphonylureas and insulin prescription when not necessary to prevent its deleterious consequences in term of hospital use, cost, and cardiovascular mortality. This evidence concerns the gene INS and Hypoglycemia.